Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03268057
Title VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Acronym CLASSICAL-Lung
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Vaccinex Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST